N-Acetyl Selank amidate
Not FDA approvedModified synthetic neuropeptide
Also known as: NA-Selank
Very thin human evidence
- Regulatory standing. Sold as a research chemical, not approved
- Anecdotal. Community reports, no controlled data
- No registered human trials. Nothing registered on ClinicalTrials.gov
- No sources. Nothing cited to verify
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
N-Acetyl Selank amidate is a chemically modified version of Selank, a synthetic peptide derived from the immune peptide tuftsin and developed in Russia. The N-acetyl and amidate modifications are claimed to increase stability and potency compared with Selank, but this is not documented in published research. Selank itself is thought to influence GABA signaling and certain neurotransmitter and immune pathways.
What the evidence shows
There are no registered human trials and no published papers on this specific modified form, so any claimed effects rest on community reports and extrapolation from Selank. Selank has some limited Russian clinical research, but those findings cannot be assumed to apply to this variant.
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Sources
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.